No insider purchase over the last 90 days. The latest, by Forest Laboratories, LLC, was filed 07 Jul 2014.
Furiex Pharmaceuticals, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Furiex Pharmaceuticals, Inc. The previous disclosure was published on 7 July 2014.
Over the whole record (from 2010), the tally stands at 53 purchases and 25 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
25 of 148 declarations
Furiex Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing medications for chronic disease treatment. It emphasizes innovation and research in the healthcare sector.